Cellular Bioengineering, Inc.
Biotechnology ResearchHawaii, United States2-10 Employees
Cellular Bioengineering, Inc. (CBI) is a Hawaii-based biotechnology research company operating as an accelerator for disruptive technologies with applications in biomedicine and biodefense. Its core activity centers on identifying innovative ideas and nurturing them into mature products that can impact health care and national security, through development, licensing, or acquisition of intellectual property and subsequent incubation toward practical end uses. The organization positions itself within the biotechnology sector as a developer and incubator of IP across its operating divisions, each contributing to wellness and safety on a global scale. Based in Honolulu, CBI emphasizes advancing technologies at various development stages to deliver tangible health and security outcomes, aligning with a mission to improve well-being and protect populations. The company operates with a small team and maintains a stated focus on creating and accelerating solutions that can function across multiple sectors in health and homeland security. A recent development highlighted in its profile involves bringing forward suites of technology that have had an impact on health care and homeland security at various stages of development.